Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Acceleration × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphatic Metastasis 1 Deception 1 Breast Neoplasms 1

Interventions

Trastuzumab 521 Paclitaxel 474 Cyclophosphamide 469 Docetaxel 414 Capecitabine 352 Letrozole 311 Fulvestrant 270 Doxorubicin 246 Tamoxifen 229 Carboplatin 225 Anastrozole 197 Radiotherapy 193 exemestane 186 Epirubicin 171 Bevacizumab 166 palbociclib 150 Lapatinib 145 Vinorelbine 143 pertuzumab 141 Gemcitabine 139 pembrolizumab 136 Surveys and Questionnaires 119 Exercise 111 Magnetic Resonance Spectroscopy 110 eribulin 103 Fluorouracil 102 Albumin-Bound Paclitaxel 100 Blood Specimen Collection 96 130-nm albumin-bound paclitaxel 91 Everolimus 87

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03280719 2024-09-19

PRO-SURF

University Hospital, Ghent

Phase NA Completed

Breast Neoplasms, Deception, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡